1. Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur J Cardiothorac Surg. 2019;55(1):116–32.
2. Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK, Henry T, et al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198(7):839–49.
3. Chang LC, Hua CC, Liu YC, Chu CM, Chen HJ, Lee N. Pleural fluid viscosity may help identifying malignant pleural effusions. Respirology. 2008;13(3):341–5.
4. Yetkin O, Tek I, Kaya A, Ciledag A, Numanoglu N. A simple laboratory measurement for discrimination of transudative and exudative pleural effusion: pleural viscosity. Respir Med. 2006;100(7):1286–90.
5. Cheah HM, Fitzgerald D, Louw A, Creaney J, Lee YCG. Hyaluronic acid in viscous malignant mesothelioma pleural effusion. Respirol Case Rep. 2021;9(1):e00694.